ARCHIVES

Retrospective Data Clean-up Can’t Help C225 Phase II Trial; Protocol Far Too “Fuzzy”

This article is from The Cancer Letter archive.

Vol. 28 No. | March 8, 2002

Download PDF Visit The Full Archive

Related Articles

Buenos Aires Academy Denies Argentina Prosecutes Scientist

July 28, 1978

DCPC Board Backs Diet Fit Trial

October 20, 1989

In Brief – Control Of Many Cancer Forms By End Of The Century, Frederickson Tells House Committee

April 6, 1979

Adherez Issued U.S. Patent for Catenin Molecule Inhibition.

July 4, 2003

No Interest Seen Yet In Specialized Centers For Environmental Carcinogenesis

September 26, 1975

Darbepoetin Didn’t Decrease Blood Transfusions, Lowered Overall Survival, Study Finds

April 27, 2007